Martin Lewis investigation into Holland & Barrett prompts major change
The scheme allows shoppers to schedule regular delieveries of products at a discounted price. The customers get a fixed percentage off the standard price of the item, often between 20% and 45% off, as well as free delivery on orders over £10. However, research by MoneySavingExpert.com that took place over a five month period, revealed a number of faults, including that shoppers would have actually saved more without the scheme.
As a result, the health giant which has more than 700 stores in the UK, has said it will carry out a review of the scheme, in a major change. However, company bosses defended 'Subscribe & Save', highlighting that customers get consistently better prices than if they were to make one-off purchases.
Price checks of 10 products were carried out over 100 separate days between July 29, 2024 and January 17, 2025 and it was found that in 59% of the cases it was cheaper to buy the product as a one-off.
On top of that, the research revealed that customers would have actually lost out on savings of 75p right up to £3.50 and in worst cases, they could have overpaid by as much as a huge £39.99.
Holland & Barrett website states that the Subscribe & Save is 'the most convenient and cost-effective way' to shop, as well as that customers will be 'getting the best value'. Read More Thousands of pensioners could be missing out on free TV licence
However, it does not factor in any special offers or deals that may be available at the time of a delivery, such as 'buy one get one free', '3 for 2' or 'better than half price' sales. Therefore, as the subsription discount doesn't include various other promotions, those subscribing can sometimes end up paying more than those who buy the item as a one-off purchase.
Items that were found to always be more expensive in the Subscribe & Save scheme includes the Egmont Manuka Honey 1046+ MGO 250g, Holland & Barrett Goji Berries 210g, and Holland & Barrett Manuka Honey MGO 800+ 350g.
A 200ml bottle of Nivea Sun Kids Sensitive Protect & Care Suncream Lotion SPF 50+ was found to be cheaper to buy as a one-off product 67% of the time, while 899g of the Optimum Nutrition Gold Standard 100% Whey Protein powder in the flavour Double Rich Chocolate, was found to be cheaper as a one-off purchase 55% of the time.
Following the investigation, Holland & Barrett defended the scheme, arguing that it offers 'consistently great prices over the course of a year', with 'the convenience of an automated order' and the free delivery on orders over £10.
However, admitted that 'on rare occasions' that subscription customers 'may have paid more'. The retailer have told MoneySavingExpert.com that they will 'carry out a detailed review' to ensure that those using the Subsribe & Save scheme benefit from offers. They will also look to make the scheme's language and T&Cs clearer.
READ SOURCE
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Student loan 'SAVE plan' interest to resume: What to know
Student-loan borrowers who are on the Saving on a Valuable Education (SAVE) plan will begin seeing interest accruing on their loans again, starting on August 1. Mark Kantrowitz, student loan expert and author of "How to Appeal for More College Financial Aid," joins Mind Your Money with Allie Canal to break down the details. To watch more expert insights and analysis on the latest market action, check out more Mind Your Money here. So Mark, if you're in the SAVE plan right now, what is going to happen to your loans? Well, starting August 1st, they will start accruing interest and that interest will be added to your loan balance. Uh, it won't be capitalized just yet, but, uh, you'll be in a general forbearance for at least another month, but you should consider switching into the income-based repayment plan so that those monthly payments count towards eventual forgiveness. So you you said you should expect to be in the forbearance period for at least another month. When should borrowers expect to start making payments again? Well, the Trump administration has not yet said when that forbearance will end. Based on previous announcements from the Biden administration, it suggests that they'll restart in September, but we haven't had any information one way or another from the US Department of Education. Is there anything borrowers with loans outside of the SAVE plan need to be doing right now? Well, uh, there's several different income driven repayment plans that are ending. It's not just the SAVE repayment plan, but any uh, repayment plan that was based on income contingent repayment such as the PAYE, the pay plan, and the repay plan, those will be ending. Uh, the income contingent repayment plan, they're going to start phasing that out because of the budget reconciliation bill. Um, and in general those don't count towards forgiveness of their own, the payments you make will count towards forgiveness under income-based repayment. So if you want to eventually receive forgiveness after 20 or 25 years, you need to switch into one of those repayment plans. You mentioned No, no, continue. Okay. There's a new income driven repayment plan called the RAP plan that was introduced by this new legislation. Uh, we expect that it will become available sometime, uh, this fall. So how does RAP stand up against some of the existing plans like SAVE and I know you mentioned IBR, that's the uh, interest um, or income-based repayment plan as well. Right. So comparing RAP with IBR, the monthly payments under RAP are a little bit lower than under IBR if your income is lower than about $80,000. So if you're lower modern income, uh, you'll have lower payments, but the number of payments you have to make until the remaining debt is forgiven is 30 years whereas IBR is 20 or 25 years depending on whether you have loans from uh, before July 1, 2014 or just afterwards. And let's talk policy too. How does President Trump's bill change the student loan repayment system at this point? Right. So for new borrowers as of July 1, 2026, they will have only two repayment plans available. A standard repayment plan, which is more like an extended repayment plan. The higher your debt, the longer the repayment term that's available to you. If your debt's under $25,000, you'll have a 10-year repayment term, and it goes all the way up to a 25-year repayment term. The other repayment plan is the RAP plan which bases the payments on a percentage of your adjusted gross income ranging from 1% to 10% uh, as your income grows. If your income is over $100,000, you'll pay 10% of income, uh, towards payments on that debt, and the remaining debt will be forgiven after 30 years in repayment. And when do these go into effect these new plans under the Trump administration? Um, for new borrowers as of July 1, 2026, uh, they will be in those repayment plans. Uh, they will also be phasing out the income contingent repayment plan uh, through July 1 of 2028. And then when you're talking to borrowers, what are some general tips when it comes to them paying back their student loans and and other resources that people can turn to to try and make this an easier process because it can be very complicated. Well, they can talk to the college financial aid administrator at their college, uh, who can provide them with some insights into these plans. Um, it is going to be simpler in a way because currently there are a dozen different repayment plans, including as many as four different income driven repayment plans, two extended repayment, two graduated repayment and one standard repayment. Uh, so it is going to get simpler. Um, but the only way to tell whether you're better off with the standard repayment plan or the RAP plan is to model it out for your own particular circumstances. There are very few rules of thumb that say which is better for you when. Related Videos 4 tips to save money on back-to-school shopping US Core Capital Goods Orders Slide Amid Tariff Uncertainty India's Goyal Sees UK Trade Deal as Win-Win German Exporters Can Live With 15% Tariff, Ifo Says 擷取數據時發生錯誤 登入存取你的投資組合 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤
Politico
a day ago
- Politico
How Trump's AI orders could throw states for a loop
EXAM ROOM A day after President Donald Trump unveiled plans to accelerate the adoption of artificial intelligence in health care, one expert warns that some aspects of the initiative could complicate state laws aimed at preventing discrimination in health care. Dan Silverboard, a health care attorney at Holland & Knight, says the White House AI Action Plan's requirement that the National Institute of Standards and Technology remove references to diversity, equity and inclusion could create significant challenges for state regulations. As the nation's primary technology standards body, NIST suggests standards and guidance on AI development and implementation. Within the health care sector, there's considerable concern that AI could make decisions that discriminate against certain patients. In 2022, NIST addressed the concerns by releasing recommended practices for managing bias and discrimination in AI — which Silverboard says may soon disappear. To understand the implications of the upcoming changes to NIST, Ruth sat down with Silverboard to discuss the potential impact on patient care and state regulations. This interview has been edited for length and clarity. How do states use the NIST AI framework? The NIST framework is basically a compliance plan for addressing risk posed by AI, including discrimination. The National Association of Insurance Commissioners came out with a model bulletin that will require insurance companies to have programs to mitigate risk caused by AI, things like unfair claims practices, unfair business practices and also algorithmic discrimination. And that bulletin has been adopted, I think, in 24 states, red and blue. If you have the NIST framework in place that would satisfy this requirement. And if the NIST framework no longer specifies how to mitigate discrimination risk? It bungles that. You also have specific state laws which prohibit insurance companies from using AI in such a way that results in algorithmic discrimination, Colorado, for example, California. The NIST changes complicate the enforcement of these laws. How else might removing DEI from NIST's AI framework impact how companies and developers are designing their technology? Multinational companies have to comply with more than just U.S. law. There is EU law out there. So, how the EU requirements might conflict with the requirements that come at a federal level is anybody's guess, but a multinational company would have no choice but to comply with other standards in place on the international level. MORNING MONEY: CAPITAL RISK — POLITICO's flagship financial newsletter has a new Friday edition built for the economic era we're living in: one shaped by political volatility, disruption and a wave of policy decisions with sector-wide consequences. Each week, Morning Money: Capital Risk brings sharp reporting and analysis on how political risk is moving markets and how investors are adapting. Want to know how health care regulation, tariffs or court rulings could ripple through the economy? Start here. WELCOME TO FUTURE PULSE This is where we explore the ideas and innovators shaping health care. Silverboard isn't the only one raising concerns about the AI Action Plan. Brenda Leong, director of the AI division at legal firm ZwillGen, says the call to remove references to 'misinformation' from NIST's risk frameworks is misguided. 'AI systems' tendency to generate factually inaccurate, misleading, or confidently wrong outputs — hallucinations — is a well-documented challenge,' she said. 'The plan shifts away from acknowledging this fundamental technical and safety hazard.' Share any thoughts, news, tips and feedback with Carmen Paun at cpaun@ Ruth Reader at rreader@ or Erin Schumaker at eschumaker@ Want to share a tip securely? Message us on Signal: CarmenP.82, RuthReader.02 or ErinSchumaker.01. WORLD VIEW Hackers love Europe's hospitals, our colleague in Europe, Giedrė Peseckytė, reports. The European Union's health care sector was targeted in 309 cybersecurity incidents in 2023 — more than in any other critical sector. The cost of a major incident typically reached €300,000 or approximately $350,000. For cybercriminals, targeting health data 'is a perfect business plan,' according to Christos Xenakis, professor at the department of digital systems at the University of Piraeus, Greece. 'It's easy to steal data, and what you steal, you can sell it at a high price.' Ransomware attacks — where hackers lock data and demand a ransom — dominate the sector, an EU Agency for Cybersecurity report showed. 'They achieve two targets: One is to get the data and sell [it], and the other is to encrypt the whole system, disrupt the whole system and ask for money,' Xenakis said. Stolen data can be sold on the dark web to criminals who use it to commit identity theft, insurance fraud or blackmail. To restore disrupted systems, criminals can demand millions of euros — hackers, for instance, wanted $4.5 million for the return of the stolen data after a cyberattack on Hospital Clínic in Barcelona. The hospital refused to pay. Why it matters: Beyond the financial impact, cyberattacks pose a threat to patients' lives. The stakes became clear in a recent case in the U.K., where a patient's death was linked — among other contributing factors — to a delayed blood test result caused by a cyberattack that disrupted pathology services last summer. A critical investment: Despite the risks, only 27 percent of health care organizations in the EU have a dedicated ransomware defense program, and 40 percent don't offer any security awareness training for non-IT staff, a separate EU Agency for Cybersecurity report found. Xenakis believes the health care sector sees cybersecurity as a 'luxury,' not an essential. Health care staff are unaware of the risks, he believes, resulting in poor 'cyber hygiene.' Findings from the Finnish Innovation Fund Sitra, an independent public foundation supervised by the Finnish Parliament, back this up. While many health care organizations have cybersecurity policies in place, they're often not 'clearly communicated or consistently understood by their staff.' High personnel turnover — not just among medics but also among cybersecurity officers — further 'exacerbates training gaps and the ability to enforce cybersecurity policies.' Europe mounts a response: In response to increasing cyberattacks on health care systems, the European Commission unveiled an 'action plan' for cybersecurity in hospitals and the health care sector in January. The plan proposes establishing a European Cybersecurity Support Center for the health care sector within the EU cybersecurity agency and a specific rapid-response service. The plan also introduces 'cybersecurity vouchers,' which will enable EU countries to provide financial support to smaller health care providers for enhancing their cyber resilience. 'It's good,' said Markus Kalliola, Sitra's program director. But it 'could be stronger.' Kalliola is one of the authors of the Commission's evaluation report by Sitra, which points to murky EU governance, a lack of clear targets or budgets and a missed opportunity to establish a single functioning market for cybersecurity solutions. What's next: Whether Europe's security will feature in the commission's final hospital cybersecurity plan remains to be seen; the EU executive has just concluded a consultation and promised to put forward a refined plan by the end of the year. SMALL BYTES The Food and Drug Administration is adding more AI talent to its roster. The agency has brought on radiologist Rick Abramson to help support the agency's AI efforts, according to two current FDA staffers granted anonymity to discuss sensitive personnel matters. Abramson previously served as Vanderbilt University's first vice chair for innovation in its Department of Radiology. He also briefly served as an adviser to the Office of Management and Budget under former President Bill Clinton. The Department of Health and Human Services did not return a request for comment as of press time.
Associated Press
a day ago
- Associated Press
CDx Diagnostics Receives FDA Breakthrough Device Designation for Its WATS3D Test System for Esophageal Cancer
Novel AI-powered laboratory test for diagnosis of Barrett's esophagus, with or without dysplasia SUFFERN, NEW YORK / ACCESS Newswire / July 24, 2025 / CDx Diagnostics announced today that the U.S. Food and Drug Administration (FDA) granted Breakthrough Device Designation for its proprietary WATS3D diagnostic system, a 'first-of-a-kind' AI-powered digital pathology system using wide area transepithelial sampling for the diagnosis of Barrett's esophagus and early neoplastic alterations in patients at risk for disease progression. 'The Breakthrough Device Designation recognizes what the volume of clinical data has shown: the WATS3D Test improves the ability to detect dysplasia in Barrett's esophagus, offering patients and physicians an improved method of detection of patients at risk of development of esophageal cancer,' said Robert Odze, MD, a leading gastrointestinal pathologist. To meet the requirements for FDA Breakthrough Device Designation, CDx Diagnostics submitted technical and clinical evidence from large multi-center studies showing that the WATS3D Test is 'more effective' than the Seattle biopsy protocol for the diagnosis of Barrett's esophagus, dysplasia and esophageal cancer. 'With data from greater than 23,000 patients, the WATS3D Test continues to demonstrate its potential to detect early-stage neoplastic disease that might be missed with conventional biopsies,' said Karen Hoffman, MD, Director of R&D at CDx Diagnostics. 'This designation recognizes the science behind our platform and supports our ongoing efforts to improve early detection of patients at risk.' The WATS3D Test System leverages proprietary artificial intelligence (AI) enabled algorithm for analysis of high-resolution digital pathology using novel 3-dimensional images from specimens collected using the WATS3D brush to identify precancerous and cancerous cells and assess the risk of progression to cancer. The WATS3D System was developed by CDx Diagnostics and is performed in the company's CLIA-certified, CAP accredited, New York state licensed clinical laboratory in Suffern, NY. For more information, visit or contact us at [email protected]. About CDx Diagnostics CDx Diagnostics' mission is to Empower Physicians with Innovative Technology to Prevent Esophageal Cancer, One Patient at a Time. CDx Diagnostics is changing the landscape of cancer prevention and diagnosis through innovative AI-driven digital pathology solutions developed and performed in the company's CLIA-certified, CAP accredited clinical laboratory in Suffern, New York. The company's first advanced diagnostic test- the WATS3D Test system powered by the WATS3D Esophageal AI Algorithm - has FDA Breakthrough Device Designation for the diagnosis of Barrett's esophagus (BE), with and without dysplasia. About the WATS3D Test System The WATS3D Test system is an AI-powered digital pathology test system that helps prevent the progression of neoplasia via more effective identification of Barrett's esophagus (BE), low-grade dysplasia (LGD), high-grade dysplasia (HGD), and esophageal adenocarcinoma (EAC). Developed and performed by CDx Diagnostics, the WATS3D Test leverages artificial intelligence (AI) enabled analysis using the WATS3D Esophageal AI Algorithm and 3D digital imaging of samples collected using a WATS3D brush to identify precancerous and cancerous cells and evaluate the risk of progression to cancer. The WATS3D Test has been used to analyze over 400,000 patient samples to identify those requiring earlier intervention, reduce time to treatment, and improve patient outcomes. Contact Information William Standwill Marketing [email protected] 845-777-7000 SOURCE: CDx Diagnostics press release
